Clinical trial
Pilot-Study of Thalidomide in Amyotrophic Lateral Sclerosis (ALS)
NCT00231140 · Charite University, Berlin, Germany, Other · Terminated
Key facts
| NCT number | NCT00231140 |
|---|---|
| Title | Pilot-Study of Thalidomide in Amyotrophic Lateral Sclerosis (ALS) |
| Official title | Randomized, Open, Parallel Group Study for the Evaluation of an Oral Dose of 100 mg Thalidomide and Subsequent Dose Escalation of 400 mg Thalidomide in Combination With Riluzole in Patients With Amyotrophic Lateral Sclerosis (ALS) |
| Lead sponsor | Charite University, Berlin, Germany, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Amyotrophic Lateral Sclerosis (ALS) |
| Intervention type | Drug |
| Interventions | Thalidomide (drug) |
| Enrollment | 40 |
| Start date | Dec 1, 2005 |
| Completion | Aug 1, 2006 |
| First posted | Oct 4, 2005 |
| Last update posted | Jan 19, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: